FDA

Latest Stories

A pig kidney that has been "decelled" is held by a technician in a Micromatrix laboratory on Tuesday, Dec. 8, 2022, in Eden Prairie, Minn. This is a pig kidney that's gradually being transformed to look and act like a human one, part of scientists' long quest to ease the nation's transplant shortage by bioengineering replacement organs. (AP Photo/Andy Clayton-King)

Making pig livers humanlike in quest to ease organ shortage

By Lauran Neergaard - Associated Press

The Food and Drug Administration building is seen on Dec. 10, 2020, in Silver Spring, Md. (AP Photo/Manuel Balce Ceneta) **FILE**

Drugmaker Accord recalls vials of antibiotic due to product mix-up

By Brad Matthews - The Washington Times

Only a few scoops are left in a mother's next to last can of baby formula in Laurel, Md., on Monday, May 23, 2022. On Friday, Sept 30, 2022, U.S. regulators unveiled their plan to allow foreign baby formula manufactures to stay on the market, an effort at diversifying the nation's tightly concentrated industry and preventing future shortages. (AP Photo/Jacquelyn Martin, File)

Possible contamination at third-party packager leads to recall of ByHeart baby formula

By Brad Matthews - The Washington Times

FILE - Baby formula is displayed on the shelves of a grocery store in Carmel, Ind. on May 10, 2022. On Tuesday, Dec. 6, 2022, a panel called for changes at the FDA, the federal agency that oversees most of the nation's food supply, saying revamped leadership, a clear mission and more urgency are needed to prevent illness outbreaks and to promote good health. Experts called the report a strong “first step” to addressing longstanding internal issues that have contributed to problems such as the contaminated infant formula that led to a nationwide shortage this year. (AP Photo/Michael Conroy, File)

Panel calls for stronger leadership of FDA foods program

By Jonel Aleccia - Associated Press

FILE - Syringes and colorful bandages are prepared as children from local schools prepare to get COVID-19 vaccines in Pittsfield, Mass., on Monday Dec. 13, 2021. A review by federal health officials finds that Pfizer's COVID-19 vaccine appears safe and effective for children under 5, the only group not currently eligible for vaccination. The review issued Sunday, June 12, 2022, by the Food and Drug Administration is a key step toward a decision on vaccinations for babies, toddlers and preschoolers, perhaps as soon as June 21. (Ben Garver/The Berkshire Eagle via AP, File)

Pfizer, BioNTech now siccing experimental COVID shots on babies

By Cheryl K. Chumley - The Washington Times

Oyster are collected in a crate, Sunday, April 25, 2021, in Brunswick, Maine. Oysters from the farm are being used to establish a new population in New Hampshire. (AP Photo/Robert F. Bukaty) **FILE**

FDA warning: Don’t consume raw oysters sold in 13 states

By Brad Matthews - The Washington Times

This 2002 electron microscope image made available by the Centers for Disease Control and Prevention shows a Listeria monocytogenes bacterium, responsible for the food-borne illness listeriosis. (Elizabeth White/CDC via AP) **FILE**

Enoki mushrooms recalled amid listeria outbreak in Michigan and Nevada

By Brad Matthews - The Washington Times

Boxes of the drug mifepristone line a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. Abortion opponents who helped challenge Roe v. Wade filed a lawsuit Friday, Nov. 18, 2022 that takes aim at medication abortions, asking a federal judge in Texas to undo decades-old approval of the preferred method of ending pregnancy in the U.S. (AP Photo/Allen G. Breed, File)

Lawsuit seeks to reverse FDA’s ‘reckless’ approval of abortion pills

By Valerie Richardson - The Washington Times

This July 3, 2018, file photo from New York shows a Narcan nasal device that delivers naloxone. (AP Photo/Mary Altaffer) ** FILE **

Over-the-counter naloxone could be coming to pharmacies, FDA says as it mulls change

By Brad Matthews - The Washington Times

Snake River sockeye salmon that returned from the Pacific Ocean to Idaho over the summer swim in a holding tank at the Eagle Fish Hatchery in southwestern Idaho. (Dan Baker/Idaho Fish and Game via AP, File)

Salmon sold at Giant grocery stores in region recalled due to listeria risk

By Brad Matthews - The Washington Times

This image provided by Covis Pharma shows packaging for the company's Makena medication. A panel of federal advisers says the drug intended to prevent premature births should be withdrawn because it doesn't work. The recommendation is non-binding but clears the way for the Food and Drug Administration to remove the drug from the market. The FDA deemed the drug ineffective and called for its removal in 2020. But manufacturer Covis Pharma has challenged that decision, setting up this week's public hearing to discuss the drug. (Covis Pharma via AP)

FDA panel backs removal of unproven pregnancy drug

By Matthew Perrone - Associated Press

In this July 25, 2005, photo, the offices of Teva Pharmaceuticals North America are seen in Horsham, Pa. At least a half-dozen companies that make or distribute prescription opioid painkillers are facing a federal criminal investigation of their roles in a nationwide addiction and overdose crisis. The Wall Street Journal first reported the investigation Tuesday, Nov. 26, 2019, citing unnamed sources familiar with the probe. (AP Photo/George Widman) **FILE**

Supply shortage hits Adderall and generic versions of the ADHD medicine

By Brad Matthews - The Washington Times

A Jackson, Miss., resident receives a Pfizer booster shot from a nurse at a vaccination site Feb. 8, 2022. Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11, Monday, Sept. 26. Already 4.4 million Americans have received one of the updated boosters since they rolled out earlier this month for anyone 12 and older. (AP Photo/Rogelio V. Solis, File)

FDA clears updated COVID boosters for kids as young as 5

By Lauran Neergaard - Associated Press

Falafel brand recalled after 20 people get sick in six states

By Brad Matthews - The Washington Times

Only a few scoops are left in a mother's next to last can of baby formula in Laurel, Md., on Monday, May 23, 2022. On Friday, Sept 30, 2022, U.S. regulators unveiled their plan to allow foreign baby formula manufactures to stay on the market, an effort at diversifying the nation's tightly concentrated industry and preventing future shortages. (AP Photo/Jacquelyn Martin, File)

U.S. outlines plan for long-term baby formula imports

By Matthew Perrone - Associated Press

This combination of 2022 and 2020 file photos shows logos for the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration. (AP Photo/Ron Harris, Manuel Balce Ceneta, File)

FDA once again plays roulette with Americans’ health

By Cheryl K. Chumley - The Washington Times

This 2018 photo provided by Amylyx shows the company's co-founders Joshua Cohen, left, and Justin Klee in Cambridge, Mass. on Sept. 2, 2022. A closely watched experimental drug for Lou Gehrig’s disease is getting an unusual second look from U.S. regulators on Wednesday, Sept. 7, 2022, amid intense pressure to approve the treatment for patients with the fatal illness. Patients and their families have rallied behind the drug from Amylyx Pharma, launching an aggressive lobbying campaign and enlisting members of Congress to push the Food and Drug Administration to grant approval. (Amylyx via AP, File)

FDA panel backs much-debated ALS drug in rare, 2nd review

By Matthew Perrone - Associated Press

A pharmacist injects a patient with a booster dosage of the Moderna COVID-19 vaccine at a vaccination clinic in Lawrence, Mass., on Wednesday, Dec. 29, 2021. U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain. The move on Wednesday, Aug. 13, 2022, by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. (AP Photo/Charles Krupa) **FILE**

U.S. clears updated COVID boosters targeting newest variants

By Lauran Neergaard - Associated Press

**FILE** An arrangement of Oxycodone pills sit next to a bottle in New York on Aug. 29, 2018. A long-awaited review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency's commissioner said Tuesday, Aug. 30, 2022. (AP Photo/Mark Lennihan, File)

FDA chief says long-awaited opioid review still in the works

By Matthew Perrone - Associated Press

A Northwell Health registered nurse fills a syringe with a COVID-19 vaccine at a pop up vaccination site the Albanian Islamic Cultural Center on April 8, 2021, in the Staten Island borough of New York. The Food and Drug Administration on Thursday, June 30, 2022 recommended that COVID-19 booster shots be modified to better match more recent variants of the coronavirus. (AP Photo/Mary Altaffer) **FILE**

FDA will launch new COVID-19 booster without full human testing

By Tom Howell Jr. - The Washington Times